Investors File Lawsuits Against Major Companies for Massive Losses
New Orleans, Thursday, 19 June 2025.
Lawsuits against Reckitt Benckiser, Tempus AI, Organon, and Compass Diversified arise over substantial investment losses. Lead plaintiff deadlines range from July 8 to August 12, 2025.
Reckitt Benckiser Faces Class Action Over Infant Formula
Reckitt Benckiser Group PLC, known for its popular Enfamil infant formula, has come under fire as claims surface regarding the risk of necrotizing enterocolitis (NEC) in preterm infants attributed to its products. Investors allege the company did not disclose crucial safety information that could have significantly impacted investor decisions and share value. The class action lawsuit, named Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, argues that material misrepresentations and omissions were made by the company, violating federal securities laws [1]. Investors have until August 4, 2025, to file as lead plaintiffs in this lawsuit [1].
Tempus AI Faces Allegations of Mismanagement
Tempus AI, Inc., a leader in healthcare-related AI solutions, is embroiled in a lawsuit following allegations of mismanagement and misleading financial statements. The legal action, covering the period from August 6, 2024 to May 27, 2025, claims that Tempus overstated its AI capabilities and engaged in aggressive accounting practices. Following a report from Spruce Point Capital Management, which highlighted these discrepancies, the company’s stock saw a dramatic drop of $12.67 per share, or 19.23%, the day after these revelations were publicized. The deadline for investors to join the lead plaintiff group is August 12, 2025 [2].
Organon & Co. Under Scrutiny for Dividend Cuts
Organon & Co. is facing legal action for allegedly failing to inform investors about a strategic shift in its dividend policy, having reduced its quarterly dividend from $0.28 to $0.02, contradicting previous commitments. The subsequent investor backlash led to a significant share price decline of 27%, drawing further attention from legal entities. The lead plaintiff filing deadline is set for July 22, 2025. Analysts remain divided on Organon’s future prospects, despite ongoing challenges impacting investor sentiment [3].
Compass Diversified Experiences Investor Discontent
Compass Diversified Holdings has been put under legal scrutiny due to alleged financial misconduct, requiring the restatement of its 2024 financial documents. This revelation prompted a major stock price drop, with shares tumbling approximately 62%, reflecting sizable investor skepticism. The legal proceedings indicate systemic issues, such as accounting irregularities linked to the ‘Lugano scandal’, raising potential violations of federal securities laws. Concerned investors must file their claims by July 8, 2025 [4].